Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis

Targeting IL-6 in the treatment of inflammatory and autoimmune diseases

(2009) Changhai Ding et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Cholangiocyte proliferation and liver fibrosis

(2009) Shannon S. Glaser et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-β receptor II dominant negative mice

(2009) Yuki Moritoki et al.   HEPATOLOGY

Apotopes and the biliary specificity of primary biliary cirrhosis

(2009) Ana Lleo et al.   HEPATOLOGY

Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor β receptor type II mice

(2009) Katsunori Yoshida et al.   HEPATOLOGY

Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis

(2009) V. Barak et al.   JOURNAL OF AUTOIMMUNITY

Primary biliary cirrhosis is associated with altered hepatic microRNA expression

(2009) Kerstien A. Padgett et al.   JOURNAL OF AUTOIMMUNITY

Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration

(2009) Claudia Drucker et al.   JOURNAL OF AUTOIMMUNITY

The effects of IL-6 on CD4 T cell responses

(2008) Oliver Dienz et al.   CLINICAL IMMUNOLOGY

Activation of Interleukin-6/STAT3 in Rat Cholangiocyte Proliferation Induced by Lipopolysaccharide

(2008) Li-Ping Chen et al.   DIGESTIVE DISEASES AND SCIENCES

B Cells Suppress the Inflammatory Response in a Mouse Model of Primary Biliary Cirrhosis

(2008) Yuki Moritoki et al.   GASTROENTEROLOGY

Adoptive transfer of CD8+ T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice

(2008) Guo-Xiang Yang et al.   HEPATOLOGY

Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Rα−/− mice

(2008) Willy Hsu et al.   HEPATOLOGY

Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis

(2008) Weici Zhang et al.   HEPATOLOGY

CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis

(2008) Shinji Shimoda et al.   JOURNAL OF AUTOIMMUNITY

Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: An immunohistochemical study

(2008) Motoko Sasaki et al.   JOURNAL OF AUTOIMMUNITY

Hepatic IL-17 responses in human and murine primary biliary cirrhosis

(2008) Ruth Y.Z. Lan et al.   JOURNAL OF AUTOIMMUNITY

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

(2008) Josef S Smolen et al.   LANCET

Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis

(2007) Jorge Allina et al.   JOURNAL OF AUTOIMMUNITY